Local Tech Wire

RALEIGH, N.C. – Salix Pharmaceuticals (Nasdaq: SLXP) said Thursday that it plans to raise $200 million through the sale of notes that will come due in 2015.

Another $30 million will be set aside for an overallotment to be granted the underwriters of the offering.

For details,

Get the latest news alerts: at Twitter.